Henry Ford Hospital Medical Journal
Volume 34

Number 1

Article 2

3-1986

Science or Technology: A Challenge for Clinical Neurosciences
Stanton B. Elias

Follow this and additional works at: https://scholarlycommons.henryford.com/hfhmedjournal
Part of the Life Sciences Commons, Medical Specialties Commons, and the Public Health Commons

Recommended Citation
Elias, Stanton B. (1986) "Science or Technology: A Challenge for Clinical Neurosciences," Henry Ford
Hospital Medical Journal : Vol. 34 : No. 1 , 5.
Available at: https://scholarlycommons.henryford.com/hfhmedjournal/vol34/iss1/2

This Article is brought to you for free and open access by Henry Ford Health System Scholarly Commons. It has
been accepted for inclusion in Henry Ford Hospital Medical Journal by an authorized editor of Henry Ford Health
System Scholarly Commons.

Feature Articles

Science or Technology: A Challenge for Clinical Neurosciences

T

he clinical neurosciences have experienced dramatic growth
during the past ten years. The application of advanced technology to diagnostic procedures and treatment modalities has
distinctly altered the practice of physicians concemed with diseases of the nervous system. The dilemma confronting the practitioner is how to reconcile increasing possibilities for intervention in circumstances where the benefit to patients is uncertain.
This is particularly difficult in an era where technology has created its own market among the lay public who unrealistically believe that medicine is now capable of preserving and restoring
function in all circumstances.
The articles in the Journal demonstrate several aspects of this
issue. Redmond and Ahmad report a case of pontine hemorrhage in which the patient had excellent recovery despite early
signs that indicated likely fatahty. The accompanying editorial
by Gade provides eloquent expression to the moral and ethical
dilemmas encountered when technology can preserve life despite serious loss of function. In contrast, two articles concemed
with interventional radiology indicate the potential for continued growth of the role that technology may play in preserving
function.
Three other articles demonstrate that careful observation and
attention to clinical detail remain the mainstay of clinical practice. Teasdall reviews the utility of accurately elicited and appropriately analyzed clinical signs in the evaluation of patients with
neurological deficits. Glasberg et al describe the unexpected
finding of pathological changes in muscles from patients undergoing total knee replacement, adding another dimension to the
evaluation of patients with advanced osteoarthritis. Twyman and
Bivins present a review of the topic of the nutritional requirements of patients with severe head injury, including a series of
clinical investigations carried out over five years. Their data
challenge accepted clinical practice and lay the groundwork for
modifications in patient care protocols that could potentially reduce morbidity and mortality resulting from severe head injury.
The discussion of the extracranial-intracranial bypass study
by Diaz and Ausman addresses a stunning example of the situa-
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tion where science and technology diverge. New surgical procedures utilizing advanced technology uniformly arrive on the
medical scene to great fanfare. Physicians, generalists and specialists alike, get caught up in the excitement of discovery and
the feeling of relief that a new treatment may reduce morbidity
and mortality in our patients. It is disappointing when a promising procedure does not live up to its early promise. It is greatly
disturbing when such procedures enter the mainstream of
clinical practice before adequate testing of their utility has been
carried out.
Within the latter context, the discussion by Diaz and Ausman
holds much promise. Since the EC-IC bypass study has failed to
validate the value of this procedure in a carefully controlled
study, Diaz and Ausman conclude that cerebral revascularization procedures are not indicated in daily clinical practice. They
also call for a randomized controlled study to attempt to find
a smaller subpopulation that might benefit from a bypass
procedure. However, only 10% of patients with ischemic cerebrovascular disease are potential candidates for any surgical procedure, and of this group only 15% of cases might be identified
by physiological measures as potential candidates for intracranial bypass. A controlled study to identify surgical candidates from 1% of the stroke population may not be cost-effective, and it could prove to be difficult to identify sufficient numbers of patients to achieve statistical significance. Recognition
of the need for carefully controlled studies might appropriately
be extended to all intracranial bypass procedures. The EC-IC
bypass study tells us that new surgical procedures, in general,
must undergo the same review as new medications.
Scientific investigation does not impede the entry of valuable
treatment modalities into the mainstream of medical practice,
but science does preserve the credibility of medical practice.
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